×
About 8,283 results

ALLMedicine™ Esophagitis Center

Research & Reviews  2,278 results

Risk factors for the occurrence of peptic esophagitis following laparoscopic Heller-Dor...
https://doi.org/10.1093/dote/doab050
Diseases of the Esophagus : Official Journal of the Inter... Tsuboi K, Yano F et. al.

Jul 23rd, 2021 - Peptic esophagitis can occur as a complication of laparoscopic Heller-Dor surgery (LHD) among patients with esophageal achalasia. The goal of this study was to identify the characteristics of patients who have developed peptic esophagitis followin...

CCL24 Signaling in the Tumor Microenvironment.
https://doi.org/10.1007/978-3-030-62658-7_7 10.1146/annurev.immunol.18.1.217 10.1016/S1074-7613(00)80165-X 10.1038/nrc1388 10.1146/annurev.pharmtox.48.121806.154841 10.1016/S0167-5699(99)01469-3 10.1111/j.1349-7006.2007.00606.x 10.1016/j.yexcr.2010.02.045 10.1200/JCO.2012.46.3653 10.2174/1568010033344480 10.1006/geno.1998.5250 10.1159/000341421 10.1016/j.cyto.2010.02.016 10.1006/bbrc.1996.1463 10.1111/j.1365-2222.2009.03419.x 10.1016/j.jaci.2004.03.022 10.1016/j.anai.2009.11.003 10.1074/jbc.271.13.7725 10.4049/jimmunol.164.7.3847 10.1084/jem.185.7.1163 10.4049/jimmunol.165.12.7224 10.1172/JCI119145 10.4132/jptm.2015.10.16 10.18632/oncotarget.14095 10.3748/wjg.v23.i34.6212 10.1111/j.1398-9995.2011.02694.x 10.1158/1078-0432.CCR-07-1145 10.1034/j.1601-0825.2003.00958.x 10.1248/bpb.30.1826 10.1242/jcs.116392 10.1016/j.adro.2017.12.007 10.1667/RR3031.1 10.1016/j.cyto.2018.04.031 10.1038/s41598-017-08264-8 10.1016/j.it.2004.09.015 10.4049/jimmunol.169.5.2712 10.1016/S1471-4914(01)02090-1 10.1038/nrc704 10.1158/1541-7786.MCR-07-0391 10.1016/j.cyto.2012.10.031 10.1016/j.cyto.2015.11.018 10.4049/jimmunol.166.12.7571 10.1016/S0002-9440(10)63310-X 10.1111/jpi.12507 10.2174/0929867323666160119094313 10.1002/(SICI)1097-0142(20000401)88:7<1544::AID-CNCR7>3.0.CO;2-S 10.1016/S0385-8146(01)00135-3 10.1046/j.1442-2042.2002.00424.x 10.1046/j.1365-2559.2002.01437.x 10.1182/blood.V95.4.1207.004k34_1207_1213 10.1016/S0046-8177(96)90216-6 10.1002/jso.2930530209 10.3109/01913123.2011.578233 10.4049/jimmunol.1000446 10.1038/ni.3159 10.4236/wjcd.2013.34054 10.5411/wji.v3.i1.7 10.1136/annrheumdis-2019-215119 10.1038/nature08151 10.1182/blood-2009-02-204834
Advances in Experimental Medicine and Biology; Lim SJ

Jul 21st, 2021 - Chemokines with their network play an important role in cancer growth, metastasis, and host-tumor interactions. Of many chemokines, C-C motif chemokine ligand 24 (CCL24) has been shown to contribute to tumorigenesis as well as inflammatory disease...

Multidisciplinary Eosinophilic Esophagitis Care: A Model for Comprehensive Patient-Cent...
https://doi.org/10.1016/j.cgh.2021.07.025
Clinical Gastroenterology and Hepatology : the Official C... Sauer BG, West A et. al.

Jul 19th, 2021 - Multidisciplinary Eosinophilic Esophagitis Care: A Model for Comprehensive Patient-Centered Care through Shared Decision Making between Gastroenterology, Allergy, and Nutrition.|2021|Sauer BG,West A,McGowan EC,|

Upper Gastrointestinal Bleeding due to Concomitant Esophageal Varices and Herpes Simple...
https://doi.org/10.1097/SGA.0000000000000598
Gastroenterology Nursing : the Official Journal of the So... Ghoddoosi M, Jazi K et. al.

Jul 16th, 2021 - Herpes simplex is a cause of infectious esophagitis. Cirrhosis is the common cause of gastroesophageal varices. But concomitant occurrence of both is not common. In this report, we present a 70-year-old woman with cirrhosis and esophageal varices ...

see more →

Guidelines  9 results

Technical Review on the Management of Eosinophilic Esophagitis: A Report From the AGA I...
https://doi.org/10.1053/j.gastro.2020.02.039
Gastroenterology Rank MA, Sharaf RN et. al.

May 3rd, 2020 - Eosinophilic esophagitis (EoE) is a chronic inflammatory condition of the esophagus. Many new studies have been reported recently that describe EoE management. An expert panel was convened by the American Gastroenterological Association Institute ...

AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinic...
https://doi.org/10.1053/j.gastro.2020.02.038
Gastroenterology Hirano I, Chan ES et. al.

May 3rd, 2020 - AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters Clinical Guidelines for the Management of Eosinophilic Esophagitis.|2020|Hirano I,Chan ES,Rank MA,Sharaf RN,Stollman NH,|standards,organization & administration,stand...

AGA institute and the joint task force on allergy-immunology practice parameters clinic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135034
Annals of Allergy, Asthma & Immunology : Official Publica... Hirano I, Chan ES et. al.

Apr 27th, 2020 - AGA institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the management of eosinophilic esophagitis.|2020|Hirano I,Chan ES,Rank MA,Sharaf RN,Stollman NH,|therapeutic use,diagnosis,drug therapy,therap...

Treatment of Eosinophilic Esophagitis (EoE): Clinical Decision Support Tool.
https://doi.org/10.1053/j.gastro.2020.03.070
Gastroenterology

Apr 9th, 2020 - Treatment of Eosinophilic Esophagitis (EoE): Clinical Decision Support Tool.|2020| ,|

Spotlight: Treatment of Eosinophilic Esophagitis (EoE).
https://doi.org/10.1053/j.gastro.2020.03.069
Gastroenterology Hirano I, Sharaf R et. al.

Apr 9th, 2020 - Spotlight: Treatment of Eosinophilic Esophagitis (EoE).|2020|Hirano I,Sharaf R,Stollman N,Wang K,Falck-Ytter Y,|standards,organization & administration,standards,methods,standards,diagnosis,immunology,therapy,methods,standards,complications,diagno...

see more →

Drugs  599 results see all →

Clinicaltrials.gov  137 results

Food Antigen in Eosinophilic Esophagitis
https://clinicaltrials.gov/ct2/show/NCT02434705

May 5th, 2020 - One of the putative mechanisms of eosinophilic esophagitis is exposure of food antigens to antigen recognition cells in the esophageal mucosa that initiates a chronic allergy-based inflammatory response . It is believed that this exposure is facil...

Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy
https://clinicaltrials.gov/ct2/show/NCT02577393

Apr 27th, 2020 - The investigators conducted this phase II study of EGCG therapy protection of the esophagus from damage induced by radiotherapy. In order to observe the effectiveness of EGCG, esophageal toxicity was recorded weekly using a grading scale based on ...

SUPR-3D: Simple Unplanned Palliative Radiotherapy Versus 3D Conformal Radiotherapy for Patients With Bone Metastases
https://clinicaltrials.gov/ct2/show/NCT03694015

Feb 20th, 2020 - For this study, SUPR (simple unplanned palliative radiotherapy) refers to the delivery of radiation to the treatment area with a simple technique, either two opposed fields (parallel opposed pair), or a single direct field. The entire portal is ex...

Reflux-Induced Oxidative Stress in Barrett's Esophagus: Response, Repair, and Epithelial-Mesenchymal-Transition
https://clinicaltrials.gov/ct2/show/NCT02579460

Feb 4th, 2020 - Gastroesophageal reflux disease (GERD) and its complication, Barrett's esophagus (BE), are risk factors for esophageal adenocarcinoma. In BE, GERD causes inflammation with oxidative DNA damage and genomic instability that contributes to carcinogen...

Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis
https://clinicaltrials.gov/ct2/show/NCT02493335

Jan 30th, 2020 - The purpose of this study is to prove the superiority of a 48-weeks treatment with budesonide orodispersible tablets versus placebo for the maintenance of clinico-pathological remission in patients with eosinophilic esophagitis.

see more →

News  275 results

Esophageal Dilation Using a Novel Attachment Cap Clinically Effective in EoE
https://www.medscape.com/viewarticle/952075

May 31st, 2021 - NEW YORK (Reuters Health) - In adults with eosinophilic esophagitis (EoE), endoscopic treatment of esophageal strictures using a novel attachment cap is technically feasible, safe and offers significant short-term improvement in symptoms, research...

Mylan Initiates Voluntary Nationwide Recall of Three Lots of Nizatidine Capsules, USP, Due to the Detection of Trace Amounts of NDMA (N-Nitrosodimethylamine) Impurity Found in the Active Pharmaceut...
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/mylan-initiates-voluntary-nationwide-recall-three-lots-nizatidine-capsules-usp-due-detection-trace

Summary Company Announcement Date: January 08, 2020 FDA Publish Date: January 08, 2020 Product Type: Drugs Reason for Announcement: Recall Reason Description NDMA (Nitrosodimethylamine) impurity Company Name: Mylan N.V. Brand Name: Brand Name(s) M...

Web-Based Patient Education Cuts Down Upper GI Endoscopy for Dyspepsia
https://www.medscape.com/viewarticle/950605

May 5th, 2021 - (Reuters Health) - Patients with uninvestigated dyspepsia may be less likely to require an upper gastrointestinal tract endoscopy if they participate in web-based patient education, a small clinical trial suggests. Researchers followed 119 patient...

Fast Five Quiz: Gastroesophageal Reflux Disease Management
https://reference.medscape.com/viewarticle/945392

Feb 11th, 2021 - Gastroesophageal reflux disease (GERD) affects as many as 28% of North American residents. Marked by an excessive backup of gastric contents into the esophagus leading to troublesome symptoms and/or complications, it can result from dysfunction of...

Antibody Shows Promise in Eosinophilic Gastritis/Duodenitis
https://www.medscape.com/viewarticle/939992

Oct 28th, 2020 - In a phase 2 trial in eosinophilic gastritis and duodenitis, an anti–Siglec-8 antibody greatly reduced populations of eosinophilic cells, and also led to improved symptoms. The sponsoring company, Alkalos, is currently conducting a phase 3 trial i...

see more →

Patient Education  15 results see all →